Berthe A. M. van der Geest

Jan 3, 2025 | nature.com | Jasper Been |Berthe A. M. van der Geest |Maryse C. Cnossen |Hanneke W. Harmsen van der Vliet |Christian V. Hulzebos |Erwin Ista | +2 more

Neonatal hyperbilirubinemia is a leading cause of hospitalization during the first week of life. Recent research suggest that phototherapy, the standard treatment, can be safely and effectively administered at home. Some Dutch hospitals have already adopted home-based phototherapy. The TREAT Jaundice@home study aims to contribute to its broader implementation across the Netherlands. Understanding the perspectives, perceptions, and needs of healthcare professionals is essential for facilitating this implementation. This cross-sectional survey targeted pediatricians, midwives, and maternity care assistants with and without prior experience with phototherapy at home. The 82-item questionnaire covered respondent background, experience, interests, motivation, responsibilities, logistics, collaboration, knowledge, indications and contraindications, financial aspects, and implementation readiness. The study included responses from 16 pediatricians, 90 community midwives, and 514 maternity care assistants. Findings indicate a positive reception of phototherapy at home, regardless of prior experience. The majority expressed satisfaction, recognized potential benefits, and/or demonstrated a willingness to adopt this innovation. Key challenges identified include the need for information, the lack of guidelines, coordination and collaboration issues, and concerns about financial compensation. Phototherapy at home is well-received by healthcare professionals. Addressing the identified challenges is imperative for successful implementation, ultimately benefiting neonates, their families, and healthcare systems.